Wegovy vs Ozempic: The Same Drug at Two Doses

Wegovy (semaglutide, Novo Nordisk) vs Ozempic (semaglutide, Novo Nordisk)

Last verified May 2026

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The verdict

Both are semaglutide from the same manufacturer, with different target doses and different labels. Wegovy's usual weight-management dose is 2.4 mg, with a 7.2 mg maximum for some adults; Ozempic tops out at 2 mg for diabetes. Each has its own cardiovascular result in its own population: SELECT's MACE −20% in obesity without diabetes, and SUSTAIN-6's −26% in diabetes at high risk. Both have NovoCare self-pay prices: $349 a month for Wegovy and $349–$499 for Ozempic. Which one you can get is usually decided by which diagnosis is on the prescription.

Side-by-side comparison

Wegovy vs Ozempic, side by side
FieldWegovyOzempic
Active ingredientSemaglutideSemaglutide
FDA-labeled indicationChronic weight management; CV risk reduction in obesity (Mar 2024)Type 2 diabetes; CV risk reduction in T2D + established CVD
Max labeled dose2.4 mg once weekly2.0 mg once weekly
Pivotal weight-loss trial−14.9% TBWL / 68 wk (STEP-1, 2.4 mg)−6.2% TBWL / 68 wk (STEP-2, 1.0 mg in T2D)
MechanismGLP-1 receptor agonistGLP-1 receptor agonist
Cardiovascular outcome trialMACE −20% in obesity without diabetes (SELECT, 2023)MACE −26% in T2D + high CV risk (SUSTAIN-6, 2016)
Cash price (manufacturer direct)$349/mo via NovoCare ($199 for the first two fills for new patients)$349–$499/mo via NovoCare self-pay ($499 at 2 mg)
Commercial insurance PA criteriaBMI ≥30 (or ≥27 + comorbidity); obesity benefit (often excluded)A1c ≥6.5% + metformin trial; T2D benefit (broadly covered)

What each one costs in the compounded market

Standing monthly cash prices from the 734 sellers on this register. These are compounded preparations, not the approved products compared above.

Wegovy and Ozempic — semaglutide

from $47 /mo

463 sellers publish a standing price. This is the lowest of all 463; the median is $174 a month.

Where to get semaglutide — a selection of sellers, not a price ranking

⚠ A compounded preparation is not the approved product. No agency has reviewed that specific preparation for safety, effectiveness or manufacturing quality, and the legal ground under compounding these molecules narrowed when the shortages closed. The price gap is real, and so is the difference in oversight. Every seller, with its price record.

Frequently asked questions

Are Wegovy and Ozempic the same drug?

Chemically, yes — both are semaglutide. They are sold under different names for different approved uses, and usually at different doses and different prices. That is a labeling and commercial distinction, not a pharmacological one, which is why a prescription for one is not automatically interchangeable with the other at the pharmacy counter.

Is Wegovy or Ozempic cheaper?

On the manufacturers' own cash pricing: Wegovy at $349/mo via NovoCare ($199 for the first two fills for new patients), Ozempic at $349–$499/mo via NovoCare self-pay ($499 at 2 mg). That is the list-price comparison, and it is not what most people pay. What you actually pay depends on whether your plan covers it, which formulary tier it sits in, and whether you have met your deductible — and for many people the honest comparison is between an insured copay and a cash-pay compounded alternative rather than between these two figures.

Does either one have better cardiovascular evidence?

Neither has a clear edge. Wegovy: MACE −20% in obesity without diabetes (SELECT, 2023). Ozempic: MACE −26% in T2D + high CV risk (SUSTAIN-6, 2016). This matters more than it first appears — a drug with a completed outcomes trial has evidence about events that matter, not only about weight, and that is often what decides coverage.

What does a compounded version of each actually cost?

Compounders sell the molecule, not either brand, so one figure covers both: across the 734 sellers in this register, the cheapest standing monthly cash price we hold for compounded semaglutide is $47 a month. A compounded preparation is not the approved product: no agency has reviewed that specific preparation for safety, effectiveness or manufacturing quality, and the legal ground under compounding these molecules narrowed once the shortages closed. The price gap is real and so is the difference in oversight.

Can I switch from Wegovy to Ozempic?

People move between them regularly, since it is the same molecule — but the dose ladders differ, so a prescriber has to map where you land rather than matching the number. Do not assume your current dose transfers.

Which one should I ask for?

That is a prescriber's call, and anyone answering it from a table is guessing. What a page like this can do is tell you what the trials measured, what the manufacturers charge, and where the evidence is still missing, so the conversation starts from the record rather than from an advertisement.

References

  1. 1.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. PMID: 33567185.
  2. 2.Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021. PMID: 33667417.
  3. 3.Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). N Engl J Med. 2016. PMID: 27633186.
  4. 4.Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023. PMID: 37952131.
  5. 5.Novo Nordisk. WEGOVY (semaglutide) injection — FDA prescribing information. DailyMed (NIH/NLM). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  6. 6.Novo Nordisk. OZEMPIC (semaglutide) injection — FDA prescribing information. DailyMed (NIH/NLM). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  7. 7.Novo Nordisk. NovoCare self-pay pricing for Wegovy — $199 a month for the first 2 fills for new patients, then $349 ($399 for Wegovy HD 7.2 mg). NovoCare. 2026. https://www.novocare.com/patient/medicines/wegovy/savings-offer.html

See the full drug-vs-drug verdict index or provider rankings.